TSHA
Taysha Gene Therapies Inc
4.60$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | +88.1% | -49.1% | +98.2% | -24.1% | -5.4% | -67.4% | +60.8% | +13.1% | +13.8% | -13.7% | -100.0% | – | -100.0% | – | – | |
| – | – | – | – | – | – | +165.6% | +95.3% | +25.9% | +23.0% | +16.7% | +0.0% | +459.7% | -62.4% | +11.4% | -52.9% | +10.6% | -11.2% | -7.7% | – | – | – | – | +3.2% | +4.5% | -1.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +395.1% | -58.5% | +160.9% | -18.4% | -5.4% | -67.4% | +60.8% | +13.1% | +13.8% | -13.7% | -114.4% | – | -105.7% | – | – | |
| – | +458.7% | -44.5% | +261.1% | +10.9% | +94.6% | +28.5% | +29.0% | -4.1% | +0.7% | -38.4% | -28.6% | -17.4% | -9.7% | +58.2% | -40.4% | +7.6% | +62.9% | -27.0% | -0.8% | +2.5% | +1.6% | +29.4% | +26.4% | -3.2% | +37.1% | +14.3% | – | |
| – | -45.3% | +1,254.3% | +320.3% | +53.3% | +34.9% | +23.0% | +10.1% | +5.9% | -2.9% | -14.0% | -12.0% | -15.5% | +19.2% | -31.6% | +43.4% | -21.8% | +5.4% | +3.6% | +7.7% | -16.1% | +23.1% | +5.4% | -3.7% | +6.7% | +9.6% | +25.5% | – | |
| – | +400.8% | -28.2% | +275.1% | +22.1% | +74.7% | +27.1% | +24.3% | -1.9% | -0.1% | -32.8% | -23.7% | -16.7% | -2.7% | +21.5% | -20.0% | -1.0% | +39.8% | -19.2% | +23.5% | -20.7% | +8.1% | +21.1% | +17.4% | -0.7% | +29.0% | +9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | +5,500.0% | +17.9% | +193.9% | +179.9% | +27.3% | -2.7% | +10.6% | +45.1% | -26.2% | +72.6% | +4.8% | +2.2% | -51.5% | -95.9% | -6.9% | -11.1% | -8.3% | -13.6% | -10.5% | -11.8% | -20.0% | -25.0% | -33.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -150.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -78,692.6% | – | – | +34.7% | -39.4% | -7.5% | +1,767.6% | +22.0% | +5.3% | +38.9% | +89.3% | +4.4% | -40.8% | -122.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -150.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -148.6% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.